Israel Active

Ben Gurion University researchers published the first long-term study of stroke patient rehabilitation using Socially Assistive Robots (SARs).  The robots used speech, facial expressions, and gestures to guide and coach patients and improve outcomes.  (See also previously).

Israel’s IceCure Medical (see previously) presented the results of its three clinical studies using ProSense to treat breast cancer. Of the 389 patients treated, The ipsilateral tumor recurrence rate was 0.26%, resulting in a 99.74% recurrence-free rate.

Israel’s Restore Medical (see previously) has been granted Breakthrough Device Designation by the U.S. FDA for its transcatheter Pulmonary Artery Banding (PAB) system designed for patients suffering from left ventricle failure who currently have limited treatment options.

If you wanted to know what happened to Aerodentis (see previously) from Israel’s Dror Ortho-Design, there is good news. Aerodentis has been rebranded as Zsmile and its orthodontic system that straightens your teeth while you sleep is about to launch commercially.

4 years ago, six Israeli 9th-grade students put an experiment about brain disease progression aboard the International Space Station. The results have just been published in the June edition of Astrobiology. If repeated, it could have major implications for neurodegenerative disease treatment.

Israel’s FeelBetter (see previously) has validated its AI algorithm, using Israeli patient records, to predict and reduce the risk of multiple medicines causing side effects. FeelBetter has just partnered New Jersey’s Atlantic Health Systems with its half a million patients.

Researchers from Israel’s Ben Gurion and Canada’s British Columbia universities have discovered the pathway for cells to coordinate activity such as tissue repair.  3 to 8 local cells send Calcium ion signals to “hot-spots” inside lymph nodes, which then trigger actions and send signals back.

Magen David Adom is partnering with the Israel Midwives Organization to help women deliver their babies safely even when war prevents immediate transport to hospital. Midwives are matched to expectant mothers. Equipment is funded by the Jewish Federations of North America.

Israel’s Ministry of Health has approved the ART100 Extra-Corporeal Membrane Oxygenation and Cardiopulmonary Bypass system from Israel’s Inspira Technologies (see previously). The ART100 helps increase the level of oxygen in patients’ blood.

Researchers at Israel’s Bar-Ilan University have discovered why natural killer (NK) cells in the immune system lose their ability to fight cancer. They introduced nanoparticles that silenced the enzyme DGK alpha and the transcription factor Egr2, returning the NK cells to normal function.